Kissei Pharmaceutical Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3240600001
JPY
4,585.00
0.00 (0.00%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Dec'23
Net Sales
22,191.00
22,661.00
23,203.00
21,302.00
21,164.00
17,720.00
20,881.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
22,191.00
22,661.00
23,203.00
21,302.00
21,164.00
17,720.00
20,881.00
Raw Material Cost
11,111.00
11,714.00
11,483.00
10,785.00
10,283.00
8,944.00
10,617.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
6.00
6.00
6.00
5.00
4.00
5.00
4.00
Selling and Distribution Expenses
8,971.00
6,617.00
9,264.00
6,388.00
6,137.00
6,212.00
5,853.00
Other Expenses
-0.60
278.80
-0.60
450.00
258.20
270.70
225.90
Total Expenditure (Excl Depreciation)
20,082.00
21,125.00
20,747.00
21,678.00
19,006.00
17,868.00
18,733.00
Operating Profit (PBDIT) excl Other Income
2109
1536
2456
-376
2158
-148
2148
Other Income
3,530.00
2,739.00
4,691.00
2,194.00
3,440.00
3,384.00
1,469.00
Operating Profit (PBDIT)
6,727.00
5,435.00
8,320.00
2,979.00
6,719.00
4,374.00
4,684.00
Interest
6.00
6.00
6.00
5.00
4.00
5.00
4.00
Exceptional Items
116.00
-231.00
-2,727.00
-175.00
-70.00
118.00
-16.00
Gross Profit (PBDT)
11,080.00
10,947.00
11,720.00
10,517.00
10,881.00
8,776.00
10,264.00
Depreciation
1,088.00
1,160.00
1,173.00
1,161.00
1,121.00
1,138.00
1,067.00
Profit Before Tax
5,747.00
4,036.00
4,415.00
1,638.00
5,521.00
3,349.00
3,598.00
Tax
1,227.00
915.00
813.00
490.00
1,416.00
511.00
903.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
4,519.00
3,121.00
3,590.00
1,144.00
4,106.00
2,824.00
2,658.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
4,519.00
3,121.00
3,590.00
1,144.00
4,106.00
2,824.00
2,658.00
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
1.00
0.00
12.00
3.00
-1.00
13.00
37.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
4,520.00
3,121.00
3,602.00
1,147.00
4,105.00
2,837.00
2,695.00
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
2,07,087.00
2,09,004.00
2,10,203.00
2,19,657.00
2,19,812.00
2,20,029.00
1,96,551.00
Earnings per share (EPS)
107.87
72.91
82.65
25.86
92.88
63.8
59.17
Diluted Earnings per share
107.87
72.91
82.65
25.86
92.88
63.8
59.17
Operating Profit Margin (Excl OI)
9.5%
6.78%
10.58%
-1.77%
10.2%
-0.84%
10.29%
Gross Profit Margin
30.8%
22.93%
24.08%
13.14%
31.38%
25.32%
22.34%
PAT Margin
20.36%
13.77%
15.47%
5.37%
19.4%
15.94%
12.73%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Jun 2025 is 4.85% vs 9.58% in Jun 2024

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Jun 2025 is 10.11% vs 23.53% in Jun 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Jun 2025 is -2.50% vs 23.50% in Jun 2024

stock-summary

Interest

YoY Growth in quarter ended Jun 2025 is 50.00% vs 0.00% in Jun 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Jun 2025 has fallen from Jun 2024

Compare Quarterly Results Of Kissei Pharmaceutical Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(JPY)
Change(%)
Net Sales
22,191.00
12,618.00
9,573.00
75.87%
Other Operating Income
0.00
0.00
0.00
Total Operating income
22,191.00
12,618.00
9,573.00
75.87%
Raw Material Cost
11,111.00
3,805.00
7,306.00
192.01%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
6.00
119.00
-113.00
-94.96%
Selling and Distribution Expenses
8,971.00
7,691.00
1,280.00
16.64%
Other Expenses
-0.60
-1.50
0.90
60.00%
Total Expenditure (Excl Depreciation)
20,082.00
11,600.00
8,482.00
73.12%
Operating Profit (PBDIT) excl Other Income
2,109.00
1,018.00
1,091.00
107.17%
Other Income
3,530.00
-162.00
3,692.00
2,279.01%
Operating Profit (PBDIT)
6,727.00
1,685.00
5,042.00
299.23%
Interest
6.00
119.00
-113.00
-94.96%
Exceptional Items
116.00
-3.00
119.00
3,966.67%
Gross Profit (PBDT)
11,080.00
8,813.00
2,267.00
25.72%
Depreciation
1,088.00
829.00
259.00
31.24%
Profit Before Tax
5,747.00
734.00
5,013.00
682.97%
Tax
1,227.00
446.00
781.00
175.11%
Provisions and contingencies
0
0
0.00
Profit After Tax
4,519.00
-53.00
4,572.00
8,626.42%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
4,519.00
-53.00
4,572.00
8,626.42%
Share in Profit of Associates
0
0
0.00
Minority Interest
1.00
340.00
-339.00
-99.71%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
4,520.00
287.00
4,233.00
1,474.91%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
2,07,087.00
30,591.00
1,76,496.00
576.95%
Earnings per share (EPS)
107.87
-0.38
108.25
28,486.84%
Diluted Earnings per share
107.87
-0.38
108.25
28,486.84%
Operating Profit Margin (Excl OI)
9.50%
8.07%
0.00
1.43%
Gross Profit Margin
30.80%
12.39%
0.00
18.41%
PAT Margin
20.36%
-0.42%
0.00
20.78%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 2,219.10 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is -2.07% vs -2.34% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 4.85% vs 9.58% in Jun 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 452.00 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 44.83% vs -13.35% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 10.11% vs 23.53% in Jun 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 319.70 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 18.58% vs -25.71% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is -2.50% vs 23.50% in Jun 2024

Quarterly - Interest
Interest 0.60 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 0.00% vs 0.00% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 50.00% vs 0.00% in Jun 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 9.50%
in Jun 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 has fallen from Jun 2024